Scarica l'app Stockscreener
12.80
1.27%
0.16
Dopo l'orario di chiusura:
12.55
-0.25
-1.95%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$12.64
Aprire:
$12.7
Volume 24 ore:
290.06K
Relative Volume:
0.72
Capitalizzazione di mercato:
$563.31M
Reddito:
$159.01M
Utile/perdita netta:
$-21.72M
Rapporto P/E:
-22.86
EPS:
-0.56
Flusso di cassa netto:
$-20.63M
1 W Prestazione:
-8.38%
1M Prestazione:
-2.74%
6M Prestazione:
+111.92%
1 anno Prestazione:
+117.69%
Intervallo 1D:
$12.55
$13.01
Intervallo di 1 settimana:
$12.18
$14.15
Portata 52W:
$5.55
$15.90
Axogen Inc Stock (AXGN) Company Profile
Nome
Axogen Inc
Settore
Industria
Telefono
(386) 462-6817
Indirizzo
13631 PROGRESS BLVD., ALACHUA, FL
Confronta AXGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| AXGN | 12.80 | 563.31M | 159.01M | -21.72M | -20.63M | -0.56 |
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-11-11 | Ripresa | Jefferies | Buy |
| 2022-05-09 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2022-03-11 | Ripresa | Cantor Fitzgerald | Overweight |
| 2020-10-23 | Iniziato | Guggenheim | Buy |
| 2020-06-16 | Ripresa | Cantor Fitzgerald | Overweight |
| 2020-05-07 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2020-04-02 | Downgrade | BTIG Research | Buy → Neutral |
| 2019-08-07 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2019-07-12 | Iniziato | Canaccord Genuity | Buy |
| 2018-03-02 | Reiterato | Lake Street | Buy |
| 2018-01-05 | Ripresa | Cantor Fitzgerald | Overweight |
| 2017-11-30 | Iniziato | Jefferies | Buy |
| 2017-11-21 | Reiterato | Lake Street | Buy |
| 2017-07-31 | Iniziato | Leerink Partners | Outperform |
| 2017-06-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-03-06 | Iniziato | ROTH Capital | Buy |
| 2016-11-22 | Aggiornamento | Lake Street | Hold → Buy |
| 2016-11-07 | Reiterato | Wedbush | Outperform |
| 2016-11-03 | Downgrade | Lake Street | Buy → Hold |
| 2016-08-04 | Reiterato | Wedbush | Outperform |
| 2014-05-14 | Iniziato | Dawson James | Buy |
| 2013-10-31 | Reiterato | Ladenburg Thalmann | Buy |
Mostra tutto
Axogen Inc Borsa (AXGN) Ultime notizie
AxoGen, Inc. (NASDAQ:AXGN) Short Interest Down 8.1% in October - MarketBeat
Axogen Inc (AXGN) Shares Down 5.01% on Nov 12 - GuruFocus.com
AxoGen's SWOT analysis: nerve repair firm's stock faces growth hurdles By Investing.com - Investing.com UK
AxoGen, Inc. (NASDAQ:AXGN) Q3 2024 Earnings Call Transcript - Insider Monkey
Recent 9.2% pullback isn't enough to hurt long-term Axogen (NASDAQ:AXGN) shareholders, they're still up 152% over 1 year - Simply Wall St
Axogen Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Creative Planning Has $418,000 Stock Holdings in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
AxoGen Reports Strong Q3 2024 Revenue Growth - Yahoo Finance
Axogen Inc (AXGN) Q3 2024 Earnings Call Highlights: Strong Reven - GuruFocus.com
Axogen Inc (AXGN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements - Yahoo Canada Finance
Axogen Reports Strong Q3 Growth and FDA Progress - TipRanks
Axogen Inc earnings beat by $0.06, revenue topped estimates - Investing.com
AxoGen Q3 2024 Earnings Preview - MSN
First Light Asset Management, LLC Increases Stake in Axogen Inc - GuruFocus.com
SYK: 3 Medical Devices Stocks Poised for Solid Growth - StockNews.com
AxoGen (NASDAQ:AXGN) Trading Down 11.2%Here's Why - MarketBeat
Analysts Predict How High Axogen Inc (AXGN) Will Go. - Stocks Register
Axogen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
AxoGen: Q3 Earnings Snapshot - Marketscreener.com
Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update - GlobeNewswire
Axogen stock soars to 52-week high, hits $15.24 amid robust gains - Investing.com Australia
AxoGen (NASDAQ:AXGN) Hits New 12-Month HighHere's Why - MarketBeat
Axogen Inc (AXGN) Shares Up 3.84% on Nov 4 - GuruFocus.com
AxoGen (AXGN) Scheduled to Post Quarterly Earnings on Thursday - MarketBeat
When (AXGN) Moves Investors should Listen - Stock Traders Daily
Director Gregory Freitag Sells 25,000 Shares of Axogen Inc (AXGN) - GuruFocus.com
Semanteon Capital Management LP Acquires New Position in AxoGen, Inc. (NASDAQ:AXGN) - MarketBeat
Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024 - GlobeNewswire
Axogen (STU:LT3) Cyclically Adjusted PS Ratio : 4.57 (As of Oct. 23, 2024) - GuruFocus.com
South Korea Peripheral Nerve Injury Market Size & Outlook, 2030 - Grand View Research
Colombia Peripheral Nerve Injury Market Size & Outlook, 2030 - Grand View Research
nVerses Capital LLC Acquires Shares of 4,000 AxoGen, Inc. (NASDAQ:AXGN) - Defense World
(AXGN) Investment Analysis - Stock Traders Daily
FY2028 EPS Estimates for AxoGen Cut by Leerink Partnrs - Defense World
AxoGen (AXGN) Surges 8.2%: Is This an Indication of Further Gains? - MSN
Axogen, Inc. (NASDAQ:AXGN): Are Analysts Optimistic? - Simply Wall St
Leerink Partnrs Has Weak Outlook for AxoGen FY2028 Earnings - MarketBeat
AxoGen (NASDAQ:AXGN) Stock Price Down 4.3%Should You Sell? - MarketBeat
Exchange Traded Concepts LLC Reduces Stock Holdings in AxoGen, Inc. (NASDAQ:AXGN) - MarketBeat
Axogen Inc (AXGN) Stock Price Down 3.7% on Oct 17 - GuruFocus.com
AxoGen (NASDAQ:AXGN) Reaches New 52-Week HighTime to Buy? - MarketBeat
Axogen stock soars to 52-week high, hits $15.12 amid robust gains - Investing.com Australia
StockNews.com Upgrades AxoGen (NASDAQ:AXGN) to “Buy” - Defense World
AxoGen (NASDAQ:AXGN) Rating Increased to Buy at StockNews.com - MarketBeat
Peripheral Nerves Injury Operative A Game Changer for Global Finance Forecast-Neurorrhaphy, Nerve Grafting, Axogen, Inte – IndiaPolitics.com - IndiaPolitics.com
Peripheral Nerve Injuries Therapeutic Market Business Standards – AxoGen, Inc., Stryker, Baxter International - Cauverynews
AxoGen, Inc. (NASDAQ:AXGN) Shares Sold by Millennium Management LLC - Defense World
AxoGen, Inc. (NASDAQ:AXGN) Stake Cut by Millennium Management LLC - MarketBeat
Axogen Inc Azioni (AXGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
0.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):